Literature DB >> 26096827

Activity of synthetic chalcones in hamsters experimentally infected with Leishmania (Viannia) braziliensis.

Tatiane F P de Mello1, Bruna M Cardoso, Sara N Lopes, Heriberto R Bitencourt, Evandra M Voltarelli, Luzmarina Hernandes, Sandra M A Aristides, Maria V C Lonardoni, Thais G V Silveira.   

Abstract

The purpose of this study is to evaluate the toxicity of synthetic chalcones 1 and 2 in uninfected hamsters and anti-Leishmania activity of synthetic chalcones 1 and 2 in hamsters infected with Leishmania (Viannia) braziliensis. For the toxicity test, uninfected animals were treated with chalcones 1 and 2, and clinical and biochemical parameters and histological aspects of the liver and kidneys were assessed. Chalcones 1 and 2 were then intraperitoneally or topically administered (10 mg/kg body weight) three times per week in animals infected with promastigotes of L. (V.) braziliensis. We monitored the thickness of the infected footpads, determined parasitic load, performed histological analysis, and detected apoptosis in situ. The results were analyzed using Student's t test and Mann-Whitney test at a significance level of 5%. Neither of the chalcones showed toxicity. Chalcone 2 administered intraperitoneally significantly reduced the thickness of the infected footpad compared with the beginning of treatment. The parasite load of the lymph node and spleen was reduced in the groups treated with chalcones 1 (topical) and 2 (intraperitoneal). Chalcone 2 (topical) reduced parasite burden only in the lymph node. The histological analysis revealed reconstitution of the tissue and reductions of inflammation and apoptosis in the infected footpad in these groups. The synthetic chalcones 1 (topical) and 2 (intraperitoneal and topical) at a dose of 10 mg/kg showed anti-Leishmania activity in vivo, no renal or hepatic toxicity, and a reduction of apoptosis of the cells in the lesions. These chalcones may have substantial potential for the treatment of cutaneous leishmaniasis.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26096827     DOI: 10.1007/s00436-015-4581-1

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  30 in total

1.  Improvement of in vitro and in vivo antileishmanial activities of 2', 6'-dihydroxy-4'-methoxychalcone by entrapment in poly(D,L-lactide) nanoparticles.

Authors:  E C Torres-Santos; J M Rodrigues; D L Moreira; M A Kaplan; B Rossi-Bergmann
Journal:  Antimicrob Agents Chemother       Date:  1999-07       Impact factor: 5.191

2.  Trypanocidal and leishmanicidal properties of substitution-containing chalcones.

Authors:  Fabiane Lunardi; Michel Guzela; Andrea T Rodrigues; Rogério Corrêa; Iriane Eger-Mangrich; Mário Steindel; Edmundo C Grisard; Jamil Assreuy; João B Calixto; Adair R S Santos
Journal:  Antimicrob Agents Chemother       Date:  2003-04       Impact factor: 5.191

3.  Structure-activity relationships of antileishmanial and antimalarial chalcones.

Authors:  Mei Liu; Prapon Wilairat; Simon L Croft; Agnes Lay-Choo Tan; Mei-Lin Go
Journal:  Bioorg Med Chem       Date:  2003-07-03       Impact factor: 3.641

Review 4.  Advances in the treatment of cutaneous leishmaniasis in the new world in the last ten years: a systematic literature review.

Authors:  Olga Laura Sena Almeida; Jussamara Brito Santos
Journal:  An Bras Dermatol       Date:  2011 May-Jun       Impact factor: 1.896

5.  Leishmania braziliensis and Leishmania mexicana: experimental cutaneous infections in golden hamsters.

Authors:  H R Wilson; B S Dieckmann; G E Childs
Journal:  Exp Parasitol       Date:  1979-04       Impact factor: 2.011

6.  The contribution of the Fas/FasL apoptotic pathway in ulcer formation during Leishmania major-induced cutaneous Leishmaniasis.

Authors:  Liv Eidsmo; Susanne Nylen; Ali Khamesipour; Mari-Anne Hedblad; Francesca Chiodi; Hannah Akuffo
Journal:  Am J Pathol       Date:  2005-04       Impact factor: 4.307

7.  The antileishmanial activity of novel oxygenated chalcones and their mechanism of action.

Authors:  L Zhai; M Chen; J Blom; T G Theander; S B Christensen; A Kharazmi
Journal:  J Antimicrob Chemother       Date:  1999-06       Impact factor: 5.790

8.  Influence of Leishmania (Viannia) species on the response to antimonial treatment in patients with American tegumentary leishmaniasis.

Authors:  Jorge Arevalo; Luis Ramirez; Vanessa Adaui; Mirko Zimic; Gianfranco Tulliano; César Miranda-Verástegui; Marcela Lazo; Raúl Loayza-Muro; Simonne De Doncker; Anne Maurer; Francois Chappuis; Jean-Claude Dujardin; Alejandro Llanos-Cuentas
Journal:  J Infect Dis       Date:  2007-05-03       Impact factor: 5.226

Review 9.  Tissue damage and immunity in cutaneous leishmaniasis.

Authors:  S Nylén; L Eidsmo
Journal:  Parasite Immunol       Date:  2012-12       Impact factor: 2.280

10.  Apoptosis of Leishmania (Leishmania) chagasi amastigotes in hamsters infected with visceral leishmaniasis.

Authors:  José A L Lindoso; Paulo C Cotrim; Hiro Goto
Journal:  Int J Parasitol       Date:  2004-01       Impact factor: 3.981

View more
  1 in total

1.  Synthesis, In Silico and In Vitro Evaluation for Acetylcholinesterase and BACE-1 Inhibitory Activity of Some N-Substituted-4-Phenothiazine-Chalcones.

Authors:  Thai-Son Tran; Minh-Tri Le; Thi-Cam-Vi Nguyen; The-Huan Tran; Thanh-Dao Tran; Khac-Minh Thai
Journal:  Molecules       Date:  2020-08-27       Impact factor: 4.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.